SCHEDULE 13D

CUSIP Number(s):

03676C100

Name of reporting person

Owl Creek Asset Management, L.P.

Check the appropriate box if a member of a Group (See Instructions)

(a)

(b)

SEC use only

Source of funds (See Instructions)

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

Checkbox not checked

Citizenship or place of organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 5,411,776.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 5,411,776.00

Aggregate amount beneficially owned by each reporting person

5,411,776.00

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

Checkbox not checked

Percent of class represented by amount in Row (11)

27.7 %

Type of Reporting Person (See Instructions)

SCHEDULE 13D

CUSIP Number(s):

03676C100

Name of reporting person

Jeffrey A. Altman

Check the appropriate box if a member of a Group (See Instructions)

(a)

(b)

SEC use only

Source of funds (See Instructions)

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

Checkbox not checked

Citizenship or place of organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 139,908.00
8	Shared Voting Power 5,411,776.00
9	Sole Dispositive Power 139,908.00
10	Shared Dispositive Power 5,411,776.00

Aggregate amount beneficially owned by each reporting person

5,551,684.00

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

Checkbox not checked

Percent of class represented by amount in Row (11)

28.5 %

Type of Reporting Person (See Instructions)

Comment for Type of Reporting Person:

Note to rows (7)(9)(11)(13): Includes a total of (i) 15,416 vested and unvested restricted stock awards held by Mr. Altman and (ii) 124,492 shares of Common Stock directly held by Mr. Altman.

SCHEDULE 13D

Item 1.

Security and Issuer

(a)

Title of Class of Securities:

Common Stock, par value $0.0001 per share

(b)

Name of Issuer:

Anterix Inc.

(c)

Address of Issuer's Principal Executive Offices:

3 GARRET MOUNTAIN PLAZA, SUITE 401, WOODLAND PARK, NEW JERSEY , 07424.

Item 1 Comment:

The following constitutes Amendment No. 8 to the Schedule 13D ("Amendment No. 8"). This Amendment No. 8 amends the Schedule 13D as specifically set forth herein. Capitalized terms used herein and not otherwise defined in this Amendment No. 8 have the meanings set forth in the Schedule 13D. This Amendment No. 8 amends Items 3 and 5(a)-(c) as set forth below. This Amendment No. 8 is being filed to report a decrease in the percentage of the shares of Common Stock beneficially owned by the Reporting Persons, which decrease resulted solely from an increase in the number of outstanding shares of Common Stock reported by the Issuer.

Item 3.

Source and Amount of Funds or Other Consideration

Item 3 is hereby amended and restated in its entirety as follows: Mr. Altman holds a total of 15,416 vested and unvested restricted stock awards received in consideration for his services on the board of directors of the Issuer. Mr. Altman may be deemed to hold his stock awards for the benefit of the Owl Creek Funds.

Item 5.

Interest in Securities of the Issuer

(a)

Item 5(a) is hereby amended and restated in its entirety as follows: See rows (11) and (13) of the cover pages to this Schedule 13D for the aggregate number of shares of Common Stock and percentages of the shares of Common Stock beneficially owned by each of the Reporting Persons. The number of shares of Common Stock beneficially owned by the Reporting Persons is unchanged since the Reporting Persons' most recent filing on Form 4, filed with the Securities and Exchange Commission on August 7, 2025. The decrease in the percentage of the shares of Common Stock beneficially owned by the Reporting Persons resulted solely from an increase in the number of outstanding shares of Common Stock reported by the Issuer. The percentages used in this Schedule 13D are calculated based upon 19,506,240 shares of Common Stock outstanding, which is the sum of (i) 19,498,473 shares of Common Stock outstanding as of June 19, 2026, as reported in the Issuer's Annual Report on Form 10-K for the fiscal year ended March 31, 2026, filed with the Securities and Exchange Commission on June 25, 2026 and (ii) 7,767 shares of Common Stock underlying the unvested restricted stock awards reported herein.

(b)

Item 5(b) is hereby amended and restated in its entirety as follows: See rows (7) through (10) of the cover pages to this Schedule 13D for the number of shares of Common Stock as to which each Reporting Person has the sole or shared power to vote or direct the vote and sole or shared power to dispose or to direct the disposition.

(c)

Item 5(c) is hereby amended and restated in its entirety as follows: No transactions in the shares of Common Stock have been effected by the Reporting Persons during the past sixty (60) days.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Owl Creek Asset Management, L.P.

Signature:	/s/ Jeffrey A. Altman
Name/Title:	By: Owl Creek GP, L.L.C., General Partner, By: Jeffrey A. Altman, Managing Member
Date:	07/08/2026

Jeffrey A. Altman

Signature:	/s/ Jeffrey A. Altman
Name/Title:	Jeffrey A. Altman, individually
Date:	07/08/2026